(Q33201948)

English

Keeping cancer guidelines current: results of a comprehensive prospective literature monitoring strategy for twenty clinical practice guidelines

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

23 July 2017

Keeping cancer guidelines current: results of a comprehensive prospective literature monitoring strategy for twenty clinical practice guidelines (English)

1 reference

Europe PubMed Central

23 July 2017

Melissa Brouwers

2

object named as

Melissa C Brouwers

1 reference

Europe PubMed Central

23 July 2017

author name string

Mary E Johnston

1

1 reference

Europe PubMed Central

23 July 2017

George P Browman

3

1 reference

Europe PubMed Central

23 July 2017

publication date

1 January 2003

1 reference

Europe PubMed Central

23 July 2017

International Journal of Technology Assessment in Health Care

1 reference

Europe PubMed Central

23 July 2017

19

1 reference

Europe PubMed Central

23 July 2017

4

1 reference

Europe PubMed Central

23 July 2017

646-655

1 reference

Europe PubMed Central

23 July 2017

Recombinant human erythropoietin in the prevention of chemotherapy-induced anaemia in children with malignant solid tumours.

1 reference

https://api.crossref.org/works/10.1017%2FS0266462303000606

21 January 2018

Progress of clinical oncology guidelines development using the Practice Guidelines Development Cycle: the role of practitioner feedback

1 reference

https://api.crossref.org/works/10.1017%2FS0266462303000606

21 January 2018

The practice guidelines development cycle: a conceptual tool for practice guidelines development and implementation

1 reference

https://api.crossref.org/works/10.1017%2FS0266462303000606

21 January 2018

A comparison of efficacy of sargramostim (yeast-derived RhuGM-CSF) and filgrastim (bacteria-derived RhuG-CSF) in the therapeutic setting of chemotherapy-induced myelosuppression

1 reference

https://api.crossref.org/works/10.1017%2FS0266462303000606

21 January 2018

Funding new cancer drugs in Ontario: closing the loop in the practice guidelines development cycle

1 reference

https://api.crossref.org/works/10.1017%2FS0266462303000606

21 January 2018

Efficacy of dose-intensified MEC (methotrexate, epirubicin and cisplatin) chemotherapy for advanced urothelial carcinoma: a prospective randomized trial comparing MEC and M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin). Japanese Urothel

1 reference

https://api.crossref.org/works/10.1017%2FS0266462303000606

21 January 2018

Quality of life and survival in patients with advanced non-small cell lung cancer receiving supportive care plus chemotherapy with carboplatin and etoposide or supportive care only. A multicentre randomised phase III trial. Joint Lung Cancer Study G

1 reference

https://api.crossref.org/works/10.1017%2FS0266462303000606

21 January 2018

Long-term quality of life after treatment of laryngeal cancer. The Veterans Affairs Laryngeal Cancer Study Group

1 reference

https://api.crossref.org/works/10.1017%2FS0266462303000606

21 January 2018

Dose intensification of epidoxorubicin and cyclophosphamide in metastatic breast cancer: a randomised study with two schedules of granulocyte-macrophage colony stimulating factor

1 reference

https://api.crossref.org/works/10.1017%2FS0266462303000606

7 January 2021

based on heuristic

inferred from DOI database lookup

Lung cancer and quality of life

1 reference

https://api.crossref.org/works/10.1017%2FS0266462303000606

7 January 2021

based on heuristic

inferred from DOI database lookup

Recombinant human erythropoietin treatment for chemotherapy-related anemia in children

1 reference

https://api.crossref.org/works/10.1017%2FS0266462303000606

7 January 2021

based on heuristic

inferred from DOI database lookup

Granulocyte-macrophage colony-stimulating factor in patients with neutropenic fever is potent after low-risk but not after high-risk neutropenic chemotherapy regimens: results of a randomized phase III trial

1 reference

https://api.crossref.org/works/10.1017%2FS0266462303000606

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1017/S0266462303000606

1 reference

Europe PubMed Central

23 July 2017

1 reference

Europe PubMed Central

23 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33201948&oldid=1553361705"